This Post Was Syndicated Under License Via QuoteMedia
– Data further underscores clinical evidence of overall health improvement for type 2 Diabetes users of DarioHealth app – Data suggests MyDario™ proves to be an important tool for employers, clinics and payers in managing chronic illnessNEW YORK and CAESAREA, Israel, Aug. 6, 2019 /PRNewswire/ — DarioHealth Corp. (Nasdaq: DRIO) (“DarioHealth” or “Dario”), a leading global, digital therapeutics company and member of the Digital Therapeutics Alliance (DTx), today announced its plan to present the results of a new Dario app user study at the upcoming annual conference ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.